Key stats
- Market cap
- 32.8B
- Open
- —
- Day range
- —
- 52-week range
- $68.77 – $132.49
- Volume
- 378K
- Avg volume
- 4.51M
Q3 FY26Beat
Expected$1.53
Actual$1.75
ZTS
Zoetis Inc$80.83-$1.49-1.81%Price as of Nov 10, 2026, 9:54 AM ET
Earnings
Q2 FY26
Actual$1.65
Q1 FY26
Actual$1.42
Q4 FY25
Actual$1.37
About
Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns roughly 30% of total revenue from production animals (cattle, pigs, poultry, and so on) and nearly 70% from companion animal (dogs, horses, cats) products. Its US business is skewed even more heavily toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.
- Employees
- 14,500
- Headquarters
- Parsippany, NJ